尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Zuga Matt, 首席财务官. Insider active across 1 company, notably Acumen Pharmaceuticals, Inc.. In total, 12 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €66k. History available since 29 December 2022. The latest transaction was disclosed on 21 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Zuga Matt is Directeur Financier at Acumen Pharmaceuticals, Inc. The record shows 12 filings in total, and among the sampled recent filings, all are sales, for a total of EUR 66099 between 2021-07-08 and 2026-01-23. The largest individual filing listed is EUR 55977.60367284692 on 2023-01-03.